New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer

被引：0
|
作者：
Chuying Huo [1 ]
Bin Wu [2 ]
Dongdong Ye [1 ]
Miaochun Xu [1 ]
Shaolin Ma [3 ]
Aoshuang Cheng [1 ]
Yunyun Liu [2 ]
Chunxian Huang [1 ]
Yuhao Zhang [2 ]
Zhongqiu Lin [1 ]
Bowen Li [2 ]
Huaiwu Lu [1 ]
机构：
[1] Sun Yat-Sen University,Department of Gynecologic Oncology, Sun Yat
[2] Sun Yat-Sen University,Sen Memorial Hospital
[3] Huazhong University of Science and Technology,Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat
[4] Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,Sen Memorial Hospital
[5] Guangdong Provincial Clinical Research Center for Obstetrical and Gynecological Diseases,Department of Gynecology and Obstetrics, Union Hospital, Tongji Medical College
来源：
BMC Cancer | / 24卷 / 1期
关键词：
High-grade serous ovarian cancer; Neoadjuvant chemotherapy; Prognostic index;
D O I：
10.1186/s12885-024-13324-0
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum-Taxane Chemotherapy
    Chen, Ping
    Huhtinen, Kaisa
    Kaipio, Katja
    Mikkonen, Piia
    Aittomaki, Viljami
    Lindell, Rony
    Hynninen, Johanna
    Auranen, Annika
    Grenman, Seija
    Lehtonen, Rainer
    Carpen, Olli
    Hautaniemi, Sampsa
    CANCER RESEARCH, 2015, 75 (15) : 2987 - 2998
  • [42] CA-125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high-grade ovarian cancer
    Kessous, Roy
    Wissing, Michel D.
    Piedimonte, Sabrina
    Abitbol, Jeremie
    Kogan, Liron
    Laskov, Ido
    Yasmeen, Amber
    Salvador, Shannon
    Lau, Susie
    Gotlieb, Walter H.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2020, 99 (07) : 933 - 940
  • [43] Outcome-Related Differences in Gene Expression Profiles of High-Grade Serous Ovarian Cancers Following Neoadjuvant Chemotherapy
    Octeau, David
    Kessous, Roy
    Klein, Kathleen
    Kogan, Liron
    Pelmus, Manuella
    Ferenczy, Alex
    Greenwood, Celia M. T.
    Van Kempen, Leon C.
    Salvador, Shannon
    Lau, Susie
    Tonin, Patricia N.
    Yasmeen, Amber
    Gotlieb, Walter H.
    MOLECULAR CANCER RESEARCH, 2019, 17 (12) : 2422 - 2431
  • [44] The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc–IV high-grade serous ovarian cancer
    Xia Xu
    Fei Deng
    Mengmeng Lv
    Xiaoxiang Chen
    Archives of Gynecology and Obstetrics, 2017, 295 : 451 - 458
  • [45] Ovarian Cancer Response Scoring (OCRS): Validation of a system to quantify histopathological response to neoadjuvant chemotherapy in high-grade serous ovarian cancer
    Singh, N.
    Said, I.
    Faruqi, A.
    Gilks, B.
    Le, N.
    Boehm, S.
    VIRCHOWS ARCHIV, 2014, 465 : S40 - S40
  • [46] Prognostic 18F-FDG Radiomic Features in Advanced High-Grade Serous Ovarian Cancer
    Morales, Daniela Travaglio
    Cabrerizo, Carlos Huerga
    Garcia, Itsaso Losantos
    Poggio, Monica Coronado
    Garcia, Jose Manuel Cordero
    Llobet, Elena Lopez
    Araujo, Domenico Monachello
    Monzon, Sebastian Rizkallal
    Gadea, Luis Dominguez
    DIAGNOSTICS, 2023, 13 (22)
  • [47] Surgical factors do not impact survival in high-grade serous ovarian carcinoma patients treated with neoadjuvant chemotherapy
    Stewart, J. M.
    Tone, A. A.
    Bernardini, M. Q.
    Ferguson, S. E.
    Dodge, J.
    Laframboise, S.
    Murphy, K. J.
    Rosen, B. P.
    May, T.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 43 - 43
  • [48] Tumor-infiltrating lymphocytes expression in stage IIIc/IV of high-grade serous ovarian cancer: Variation with neoadjuvant chemotherapy and prognostic value
    Barcena, C.
    Rojas, K.
    Lema, L.
    Manso Sanchez, L.
    Rios, J.
    Garcia-Martin, R.
    Maroto, A.
    Rodriguez-Peralto, J. L.
    Ciruelos Gil, E. M.
    Mendiola, D. C.
    Paz-Ares, L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] CHEMOTHERAPY REDUCES PAR GLYCOHYDROLASE (PARG) EXPRESSION IN HIGH-GRADE SEROUS OVARIAN CANCER PATIENTS
    Ozuna, V. Lopez
    Hachim, I. Y.
    Kogan, L.
    Gotlieb, W.
    Yasmeen, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A129 - A129
  • [50] CHEMOTHERAPY REDUCES PAR GLYCOHYDROLASE (PARG) EXPRESSION IN HIGH-GRADE SEROUS OVARIAN CANCER PATIENTS
    Lopez-Ozuna, V.
    Hachim, I. Y.
    Kogan, L.
    Gotlieb, W.
    Yasmeen, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A586 - A586
12345